Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China

Objective To evaluate the prostatic hyperplasia (BPH) (CaP) in the mainland of China. prevalence of benign and prostatic cancer Methods The incidence of BPH and CaP in urological hospital was investigate d in 1997 in 26 provinces and 4 metropolises scattered over the mainland of China. The change of hospital incidences of BPH and CaP in the Institute o f Urology, Beijing Medical University from 1951 to 1997 was also reviewed. Results The incidence of BPH and CaP in 1997 in 187 hospitals scattered ove r the mainland of China was 16.1% (15 459/95 749) and 1.5% (1389/95 749), r espectively. The incidence of BPH and CaP in the Institute of Urology, Beij ing University from 1951 to 1960 was 7.6% and 0.6%, respectively, while it was 18.5% and 3.4% from 1991 to 1997. Conclusion The hospital incidence of BPH and CaP is rising rapidly in China , but CaP is still not a common disease in China.